Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.

The effect of oral antidiabetic agents on A1C levels: a systematic review and meta-analysis.

Sherifali D, Nerenberg K, Pullenayegum E, Cheng JE, Gerstein HC.

Diabetes Care. 2010 Aug;33(8):1859-64. doi: 10.2337/dc09-1727. Epub 2010 May 18. Review.

2.

Addition of thiazolidinedione or exenatide to oral agents in type 2 diabetes: a meta-analysis.

Pinelli NR, Cha R, Brown MB, Jaber LA.

Ann Pharmacother. 2008 Nov;42(11):1541-51. doi: 10.1345/aph.1L198. Epub 2008 Oct 28.

PMID:
18957626
3.

Meta-analysis: efficacy and safety of inhaled insulin therapy in adults with diabetes mellitus.

Ceglia L, Lau J, Pittas AG.

Ann Intern Med. 2006 Nov 7;145(9):665-75.

PMID:
17088580
4.

Glycemic and weight changes after persistent use of incident oral diabetes therapy: a Veterans Administration retrospective cohort study.

Huizinga MM, Roumie CL, Greevy RA, Liu X, Murff HJ, Hung AM, Grijalva CG, Griffin MR.

Pharmacoepidemiol Drug Saf. 2010 Nov;19(11):1108-12. doi: 10.1002/pds.2035.

PMID:
20878643
5.

A systematic review of the clinical effectiveness of pioglitazone in the treatment of type 2 diabetes mellitus.

Chilcott J, Tappenden P, Jones ML, Wight JP.

Clin Ther. 2001 Nov;23(11):1792-823; discussion 1791. Review.

PMID:
11768834
6.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
7.
8.

Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia.

Ushakova O, Sokolovskaya V, Morozova A, Valeeva F, Zanozina O, Sazonova O, Zhadanova E, Starceva M, Kazakova E, Saifullina M, Shapiro I, Tarasov A, Al-Tayar B, Starkova N.

Clin Ther. 2007 Nov;29(11):2374-84.

PMID:
18158078
9.

Insulin glargine: a systematic review of a long-acting insulin analogue.

Wang F, Carabino JM, Vergara CM.

Clin Ther. 2003 Jun;25(6):1541-77, discussion 1539-40. Review.

PMID:
12860485
10.

Insulin glargine provides greater improvements in glycaemic control vs. intensifying lifestyle management for people with type 2 diabetes treated with OADs and 7-8% A1c levels. The TULIP study.

Blicklé JF, Hancu N, Piletic M, Profozic V, Shestakova M, Dain MP, Jacqueminet S, Grimaldi A.

Diabetes Obes Metab. 2009 Apr;11(4):379-86. doi: 10.1111/j.1463-1326.2008.00980.x. Epub 2008 Dec 14.

PMID:
19087105
11.

Initiation of insulin glargine therapy in type 2 diabetes subjects suboptimally controlled on oral antidiabetic agents: results from the AT.LANTUS trial.

Davies M, Lavalle-Gonz√°lez F, Storms F, Gomis R; AT.LANTUS Study Group.

Diabetes Obes Metab. 2008 May;10(5):387-99. doi: 10.1111/j.1463-1326.2008.00873.x. Epub 2008 Mar 18.

PMID:
18355327
13.

Glycemic control continues to deteriorate after sulfonylureas are added to metformin among patients with type 2 diabetes.

Cook MN, Girman CJ, Stein PP, Alexander CM, Holman RR.

Diabetes Care. 2005 May;28(5):995-1000.

PMID:
15855556
14.
15.
16.

Continuous subcutaneous insulin infusion versus multiple daily injections: the impact of baseline A1c.

Retnakaran R, Hochman J, DeVries JH, Hanaire-Broutin H, Heine RJ, Melki V, Zinman B.

Diabetes Care. 2004 Nov;27(11):2590-6.

PMID:
15504991
17.

Inhaled insulin improves glycemic control when substituted for or added to oral combination therapy in type 2 diabetes: a randomized, controlled trial.

Rosenstock J, Zinman B, Murphy LJ, Clement SC, Moore P, Bowering CK, Hendler R, Lan SP, Cefalu WT.

Ann Intern Med. 2005 Oct 18;143(8):549-58.

PMID:
16230721
18.
19.

Oral antidiabetic drugs and regression from prediabetes to normoglycemia: a meta-analysis.

Phung OJ, Baker WL, Tongbram V, Bhardwaj A, Coleman CI.

Ann Pharmacother. 2012 Apr;46(4):469-76. doi: 10.1345/aph.1Q554. Epub 2012 Apr 3. Review.

PMID:
22474136
20.

The treat-to-target A1C approach to control type 2 diabetes and prevent complications.

White RD.

Adv Ther. 2007 May-Jun;24(3):545-59. Review.

PMID:
17660163

Supplemental Content

Support Center